Table I.
Percentages of patients with elevated expression of LRRC8A among 277 patients with cancer of the esophagus, stomach, duodenum, colon, rectum, liver and pancreas.
| Cancer tissue | No. of patients | No. of patients with higher LRRC8A expression in cancer than adjacent tissue | Percentage (%) |
|---|---|---|---|
| Esophagus | 24 | 3 | 12.5b |
| Stomach | 22 | 3 | 13.6b |
| Duodenum | 9 | 1 | 11.1a |
| Colon | 90 | 51 | 56.7 |
| Rectum | 90 | 52 | 57.8 |
| Liver | 21 | 1 | 4.8b |
| Pancreas | 21 | 4 | 19.0b |
a
P<0.05
b
P<0.01; vs. colon or rectum; Chi-square test. LRRC8A, leucine-rich repeat-containing 8A.